Axis-Shield : AFINION HbA1c patent granted in USA

27 June, 2008: Axis-Shield (LSE:ASD, OSE:ASD), the international in-vitro diagnostics company, announces that it has received notice of approval of its US patent application governing the measuring methodology for HbA1c within the Afinion™ cassette for detection of this important marker of diabetic patient compliance. The patent protects technology which improves HbA1c stability, precision and accuracy and has resulted in a longer product shelf-life with improved performance. The invention may also have utility for the well-established NycoCard™ product for the same marker... Axis-Shield's Press Release -

Axis-Shield, HbA1c Test on Abbott's AXSYM Analyser

19 March, 2008 : Axis-Shield (LSE:ASD, OSE:ASD), the international in-vitro diagnostics (IVD) company, announces that it has received U.S. Food and Drug Administration (FDA) marketing clearance for its novel HbA1c test, formulated to run on the widely placed, high-throughput AxSYM^® laboratory analyser from Abbott . The test, which is used to monitor treatment efficacy in patients with diabetes, will now be launched into the important US marketplace. Assay development involved novel Axis-Shield patented technology from pioneering research at its Dundee plant, which has allowed measurement of this important marker on an automated high throughput immunoassay system... Axis-Shield's Press Release -